These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 9660843

  • 1. Minimal interaction between fluoxetine and multiple-dose zolpidem in healthy women.
    Allard S, Sainati S, Roth-Schechter B, MacIntyre J.
    Drug Metab Dispos; 1998 Jul; 26(7):617-22. PubMed ID: 9660843
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic interactions between lithium and fluoxetine after single and repeated fluoxetine administration in young healthy volunteers.
    Breuel HP, Müller-Oerlinghausen B, Nickelsen T, Heine PR.
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):415-9. PubMed ID: 7582400
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance.
    Weinling E, McDougall S, Andre F, Bianchetti G, Dubruc C.
    Fundam Clin Pharmacol; 2006 Aug; 20(4):397-403. PubMed ID: 16867025
    [Abstract] [Full Text] [Related]

  • 7. Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole.
    Greenblatt DJ, von Moltke LL, Harmatz JS, Mertzanis P, Graf JA, Durol AL, Counihan M, Roth-Schechter B, Shader RI.
    Clin Pharmacol Ther; 1998 Dec; 64(6):661-71. PubMed ID: 9871431
    [Abstract] [Full Text] [Related]

  • 8. Rifampin reduces plasma concentrations and effects of zolpidem.
    Villikka K, Kivistö KT, Luurila H, Neuvonen PJ.
    Clin Pharmacol Ther; 1997 Dec; 62(6):629-34. PubMed ID: 9433391
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms.
    Barkin RL.
    Am J Ther; 2007 Dec; 14(3):299-305. PubMed ID: 17515707
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 14. Coadministration of short-term zolpidem with sertraline in healthy women.
    Allard S, Sainati SM, Roth-Schechter BF.
    J Clin Pharmacol; 1999 Feb; 39(2):184-91. PubMed ID: 11563412
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ, Stevens C, Zhou Y, Yi B, Laethem M, De Smet M, Snyder K, Hilliard D, Tanaka W, Zeng W, Tanen M, Wang AQ, Chen L, Winchell G, Davies MJ, Ramael S, Wagner JA, Herman GA.
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS, Kirby L, Kumar D, Cullen EI, Pratt RD, Hahne WA.
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [Abstract] [Full Text] [Related]

  • 18. Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons.
    Weerts EM, Ator NA, Grech DM, Griffiths RR.
    J Pharmacol Exp Ther; 1998 Apr; 285(1):41-53. PubMed ID: 9535993
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic properties and tolerability of bevirimat and atazanavir in healthy volunteers: an open-label, parallel-group study.
    Martin DE, Galbraith H, Schettler J, Ellis C, Doto J.
    Clin Ther; 2008 Oct; 30(10):1794-805. PubMed ID: 19014835
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.